共 255 条
[1]
Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-49
[2]
Ferlay J(2022)Hepatocellular carcinoma Lancet 400 1345-62
[3]
Siegel RL(2012)Treatment of hepatocellular carcinoma: a systematic review Liver Cancer 1 144-58
[4]
Laversanne M(2020)Recent updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma Int J Mol Sci 21 8165-19
[5]
Soerjomataram I(2018)Patient selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment Liver Cancer 7 104-7
[6]
Jemal A(2012)Transcatheter arterial chemoembolization: history for more than 30 years ISRN Gastroenterol 2012 480650-43
[7]
Vogel A(2015)Transarterial chemoembolization as first-line therapy for hepatocellular carcinomas infeasible for ultrasound-guided radiofrequency ablation: a retrospective cohort study of 116 patients Acta Radiol 56 70-42
[8]
Meyer T(2019)Preoperative MRI features and clinical laboratory indicators for predicting the early therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization combined with high-intensity focused ultrasound treatment Br J Radiol 92 20190073-62
[9]
Sapisochin G(2019)Magnetic resonance imaging features predictive of an incomplete response to transarterial chemoembolization in patients with hepatocellular carcinoma: a STROBE-compliant study Med (Baltim) 98 e15592-72
[10]
Salem R(2022)Preoperatively predicting early response of HCC to TACE using clinical indicators and MRI features BMC Med Imaging 22 176-8